{"id":"AIBD-0738","title":"NICE finds that DERM spots skin cancer about as accurately as dermatology review and allows it in NHS teledermatology while evidence is gathered","summary":"NICE found that DERM detects skin cancer about as accurately as teledermatology or face-to-face review. Its assessors estimated that automated DERM could about halve urgent dermatologist referrals.","date_observed":"2025-05-01","date_basis":"source publication","date_precision":"day","benefit_status":"mixed","source_collection":null,"source_entry":null,"account":"DERM, from Skin Analytics, is AI software that assesses images of skin lesions referred on the NHS urgent suspected skin cancer pathway. It can work alone or with a second read by a clinician. The National Institute for Health and Care Excellence (NICE) published an early value assessment on 1 May 2025. In one study, automated DERM detected 96.0% of cancers against 93.8% for face-to-face dermatologists. In another, it detected 94.0% against 97.0% for teledermatology, with overlapping confidence intervals. The committee found no evidence that DERM is less sensitive than either. Unity Insights, which evaluated DERM at three NHS sites, reported data suggesting that automated DERM would flag fewer non-cancer lesions for further review than teledermatology alone. NICE's assessors estimated that automated DERM could about halve urgent referrals to a dermatologist among eligible lesions. NICE allowed DERM in NHS teledermatology for a three-year evidence generation period. Most evidence came from people with white skin, so NICE requires clinician review for people with black or brown skin. It is unclear whether DERM frees dermatology capacity.","category":"aggregate result","unexpected":false,"purpose":"Skin Analytics built DERM to assess skin lesion images and identify lesions that are not cancer so that they can leave the urgent skin cancer pathway.","system":"DERM (Deep Ensemble for Recognition of Malignancy)","model_version":null,"developer":"Skin Analytics","deployer":"NHS teledermatology services in England, including sites already using DERM","location":"England, United Kingdom","domain":"Healthcare (dermatology)","segment":null,"benefit_type":"Improved Organizational Efficiency","work_activities":["4.A.1.b.1","4.A.2.b.1"],"taxonomy_note":null,"registry_ids":{},"ratings":[{"group":"organizational","depth":2,"reason":"NICE's assessors estimated that automated DERM could about halve urgent referrals to a dermatologist among eligible lesions."}],"ai_role":{"status":"assessed","statement":"Two studies compared DERM's sensitivity for cancer with face-to-face dermatologists and with teledermatology on the same lesions. The halving of referrals is an estimate by NICE's assessors."},"evidence":[{"kind":"assessment report","citation":"National Institute for Health and Care Excellence. Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment. HealthTech guidance HTG746, section 1: Recommendations. 1 May 2025, last updated 17 March 2026.","title":"Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: recommendations","url":"https://www.nice.org.uk/guidance/htg746/chapter/1-Recommendations","date":"2025-05-01","written_by":"independent","quote":"Comparative evidence suggests that DERM may be able to identify a cancer lesion with similar accuracy to teledermatology or face-to-face dermatology assessment. Using automated DERM could identify more non-cancer lesions that do not need further review and so redirect more cases to non-urgent dermatology pathways compared with using teledermatology alone."},{"kind":"assessment report","citation":"National Institute for Health and Care Excellence. HTG746, section 3: Committee discussion. 1 May 2025, last updated 17 March 2026.","title":"Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: committee discussion","url":"https://www.nice.org.uk/guidance/htg746/chapter/3-Committee-discussion","date":"2025-05-01","written_by":"independent","quote":"An analysis by the EAG suggested that, of eligible lesions, automated use of DERM could approximately halve the number of referrals to a dermatologist within the urgent skin cancer pathway."}],"replication":{"produced_by":["DERM assessed lesion images after a primary care referral to the urgent suspected skin cancer pathway.","DERM ran alone or with a clinician's second read."],"must_hold":["A clinician reviews the lesions of people with black or brown skin.","Services monitor DERM's accuracy regularly."],"echoes":[]},"paired_incident":null,"headline":"NICE assessors estimate that *DERM* could halve urgent skin referrals","metric":"could about halve urgent referrals to a dermatologist","comparator":{"against":"Face-to-face dermatologist review (DERM-003 study)","before":"93.8% sensitivity for cancer","after":"96.0% sensitivity for cancer","basis":"measured","quote":"DERM-003 (Marsden et al. 2023) reported sensitivities for detecting cancer lesions of 96.0% (95% CI 92.6 to 98.0) for automated DERM compared with 93.8% (95% CI 90.0 to 96.3) for face-to-face dermatologist review.","url":"https://www.nice.org.uk/guidance/htg746/chapter/3-Committee-discussion"},"later":null,"value":null,"developer_country":"United Kingdom","deployer_country":"United Kingdom","unrated_because":null,"brief_notes":null,"brief":null,"revisions":[{"date":"2026-10-31","change":"Added the record from the finding of NICE.","source":"https://www.nice.org.uk/guidance/htg746/chapter/1-Recommendations","editor":"AIBD"}],"confidence":"found","shade":"high","claim_status":"Found by an assessment body","claim_basis":"Sources: two independent assessment reports. The cited evidence includes no independent study or report.","case_jurisdictions":["United Kingdom"],"profile":{"case_id":"AIBD-0738","catalog_version":"1.0.0","source_fingerprint":"80784f59a37fffb8ddf491778a97ee1cc60304954f4d28fb63d1a26acbdaef47","collection_refs":[{"collection_id":"aibd","version":"2026-10-31"},{"collection_id":"querist","version":"2026-10-25"}],"source_ids":["AIBD-0738-source-0001","AIBD-0738-source-0002"],"families":{"strategic assessments":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]},"evaluations":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]},"monetary observations":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]},"institutional decisions":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]}},"fields":{"actors[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"developer":"Skin Analytics","deployer":"NHS teledermatology services in England, including sites already using DERM"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["developer","deployer"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"actors[].ownership_control":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"ai_contribution":{"state":"value_present","value":{"kind":"record_fields","fields":{"ai_role":{"status":"assessed","statement":"Two studies compared DERM's sensitivity for cancer with face-to-face dermatologists and with teledermatology on the same lesions. The halving of referrals is an estimate by NICE's assessors."}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ai_role"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"ai_relationship":{"state":"value_present","value":{"kind":"record_fields","fields":{"category":"aggregate result","ai_role":{"status":"assessed","statement":"Two studies compared DERM's sensitivity for cancer with face-to-face dermatologists and with teledermatology on the same lesions. The halving of referrals is an estimate by NICE's assessors."}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ai_role","category"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].alternatives":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].assessor_date":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].depth":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"organizational","depth":2,"reason":"NICE's assessors estimated that automated DERM could about halve urgent referrals to a dermatologist among eligible lesions."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].display_confidence":{"state":"value_present","value":{"kind":"structured","data":{"confidence":"high","evidence_word":"found","claim_status":"Found by an assessment body","basis":"Sources: two independent assessment reports. The cited evidence includes no independent study or report.","interpretation":"Existing display rule preserved; the richer outcome-specific confidence question still needs review."}},"provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].rationale":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"organizational","depth":2,"reason":"NICE's assessors estimated that automated DERM could about halve urgent referrals to a dermatologist among eligible lesions."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].rubric_version":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].status_basis":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].target":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"organizational","depth":2,"reason":"NICE's assessors estimated that automated DERM could about halve urgent referrals to a dermatologist among eligible lesions."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"availability":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"brief":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"case_kind":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"case_links[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"claims[].evidence_links":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"claims[].evidence_strength":{"state":"value_present","value":{"kind":"structured","data":{"answer":"Found by an assessment body. Sources: two independent assessment reports. The cited evidence includes no independent study or report.","evidence_word":"found","claim_status":"Found by an assessment body"}},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0738-source-0001","AIBD-0738-source-0002"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"Found by an assessment body. Sources: two independent assessment reports. The cited evidence includes no independent study or report.","inferred":false}},"claims[].missingness":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"claims[].proposition":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"cross_border_flows[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"decisions[].action_outcome":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"decisions[].grounds":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"decisions[].institution_task":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"decisions[].success_criterion":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"deployment_stage":{"state":"value_present","value":{"kind":"structured","data":{"classification":"routine use","answer":"The system was in routine use. NHS trusts were already using DERM in teledermatology, and NICE allows its use during a three-year evidence generation period.","scope":"The period and activity described in the case."}},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["account","evidence"],"source_refs":["AIBD-0738-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"The system was in routine use. NHS trusts were already using DERM in teledermatology, and NICE allows its use during a three-year evidence generation period.","inferred":false}},"economics[].amount":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].costs[]":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].counterfactual":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].currency_price_basis":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].gross_net":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].measure_type":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].period_unit":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].realization":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].recipient_payer":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].return_payback":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].valuation_method":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"evaluations[].ai_uplift":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].comparator":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].design":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].effect":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].exposure":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].id":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].measurement_method":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].metric":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].reproduction_materials":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].setting_sample":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].uncertainty_limitations":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"external_references[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"follow_up[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"human_oversight":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"id":{"state":"value_present","value":{"kind":"record_fields","fields":{"id":"AIBD-0738"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["id"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"infrastructure_dependencies[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].beneficiaries":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].beneficiary_count":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].benefit_type":{"state":"value_present","value":{"kind":"record_fields","fields":{"benefit_type":"Improved Organizational Efficiency"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["benefit_type"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].claim":{"state":"value_present","value":{"kind":"record_fields","fields":{"account":"DERM, from Skin Analytics, is AI software that assesses images of skin lesions referred on the NHS urgent suspected skin cancer pathway. It can work alone or with a second read by a clinician. The National Institute for Health and Care Excellence (NICE) published an early value assessment on 1 May 2025. In one study, automated DERM detected 96.0% of cancers against 93.8% for face-to-face dermatologists. In another, it detected 94.0% against 97.0% for teledermatology, with overlapping confidence intervals. The committee found no evidence that DERM is less sensitive than either. Unity Insights, which evaluated DERM at three NHS sites, reported data suggesting that automated DERM would flag fewer non-cancer lesions for further review than teledermatology alone. NICE's assessors estimated that automated DERM could about halve urgent referrals to a dermatologist among eligible lesions. NICE allowed DERM in NHS teledermatology for a three-year evidence generation period. Most evidence came from people with white skin, so NICE requires clinician review for people with black or brown skin. It is unclear whether DERM frees dermatology capacity.","benefit_type":"Improved Organizational Efficiency"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["account","benefit_type"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].distribution":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].duration":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].id":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].stakeholder_group":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"organizational","depth":2,"reason":"NICE's assessors estimated that automated DERM could about halve urgent referrals to a dermatologist among eligible lesions."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].status":{"state":"value_present","value":{"kind":"record_fields","fields":{"benefit_status":"mixed"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["benefit_status"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].tradeoffs":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].unexpected":{"state":"value_present","value":{"kind":"record_fields","fields":{"unexpected":false,"purpose":"Skin Analytics built DERM to assess skin lesion images and identify lesions that are not cancer so that they can leave the urgent skin cancer pathway."}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["unexpected","purpose"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"places[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"location":"England, United Kingdom","developer_country":"United Kingdom","deployer_country":"United Kingdom"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["location","developer_country","deployer_country"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"purpose":{"state":"value_present","value":{"kind":"record_fields","fields":{"purpose":"Skin Analytics built DERM to assess skin lesion images and identify lesions that are not cancer so that they can leave the urgent skin cancer pathway."}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["purpose"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"record_dates":{"state":"value_present","value":{"kind":"record_fields","fields":{"date_observed":"2025-05-01","date_basis":"source publication","date_precision":"day","revisions":[{"date":"2026-10-31","change":"Added the record from the finding of NICE.","source":"https://www.nice.org.uk/guidance/htg746/chapter/1-Recommendations","editor":"AIBD"}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["date_observed","date_basis","date_precision","revisions"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"replication.attempts[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"replication.conditions":{"state":"value_present","value":{"kind":"record_fields","fields":{"replication":{"produced_by":["DERM assessed lesion images after a primary care referral to the urgent suspected skin cancer pathway.","DERM ran alone or with a clinician's second read."],"must_hold":["A clinician reviews the lesions of people with black or brown skin.","Services monitor DERM's accuracy regularly."],"echoes":[]}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["replication"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"revision_history[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"revisions":[{"date":"2026-10-31","change":"Added the record from the finding of NICE.","source":"https://www.nice.org.uk/guidance/htg746/chapter/1-Recommendations","editor":"AIBD"}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["revisions"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sector":{"state":"value_present","value":{"kind":"record_fields","fields":{"domain":"Healthcare (dermatology)"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["domain"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sources[].access_version":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"sources[].citation_locator":{"state":"value_present","value":{"kind":"record_fields","fields":{"evidence":[{"kind":"assessment report","citation":"National Institute for Health and Care Excellence. Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment. HealthTech guidance HTG746, section 1: Recommendations. 1 May 2025, last updated 17 March 2026.","title":"Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: recommendations","url":"https://www.nice.org.uk/guidance/htg746/chapter/1-Recommendations","date":"2025-05-01","written_by":"independent","quote":"Comparative evidence suggests that DERM may be able to identify a cancer lesion with similar accuracy to teledermatology or face-to-face dermatology assessment. Using automated DERM could identify more non-cancer lesions that do not need further review and so redirect more cases to non-urgent dermatology pathways compared with using teledermatology alone."},{"kind":"assessment report","citation":"National Institute for Health and Care Excellence. HTG746, section 3: Committee discussion. 1 May 2025, last updated 17 March 2026.","title":"Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: committee discussion","url":"https://www.nice.org.uk/guidance/htg746/chapter/3-Committee-discussion","date":"2025-05-01","written_by":"independent","quote":"An analysis by the EAG suggested that, of eligible lesions, automated use of DERM could approximately halve the number of referrals to a dermatologist within the urgent skin cancer pathway."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sources[].id":{"state":"value_present","value":{"kind":"identifiers","identifiers":["AIBD-0738-source-0001","AIBD-0738-source-0002"],"role":"Existing evidence items, in their original order"},"provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"review_state":"record_mapped","coverage":"complete"},"sources[].language":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"sources[].relationship":{"state":"value_present","value":{"kind":"record_fields","fields":{"evidence":[{"kind":"assessment report","citation":"National Institute for Health and Care Excellence. Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: early value assessment. HealthTech guidance HTG746, section 1: Recommendations. 1 May 2025, last updated 17 March 2026.","title":"Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: recommendations","url":"https://www.nice.org.uk/guidance/htg746/chapter/1-Recommendations","date":"2025-05-01","written_by":"independent","quote":"Comparative evidence suggests that DERM may be able to identify a cancer lesion with similar accuracy to teledermatology or face-to-face dermatology assessment. Using automated DERM could identify more non-cancer lesions that do not need further review and so redirect more cases to non-urgent dermatology pathways compared with using teledermatology alone."},{"kind":"assessment report","citation":"National Institute for Health and Care Excellence. HTG746, section 3: Committee discussion. 1 May 2025, last updated 17 March 2026.","title":"Artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway: committee discussion","url":"https://www.nice.org.uk/guidance/htg746/chapter/3-Committee-discussion","date":"2025-05-01","written_by":"independent","quote":"An analysis by the EAG suggested that, of eligible lesions, automated use of DERM could approximately halve the number of referrals to a dermatologist within the urgent skin cancer pathway."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sources[].upstream_sources":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"strategic_assessments[]":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"strategic assessments"},"summary":{"state":"value_present","value":{"kind":"record_fields","fields":{"summary":"NICE found that DERM detects skin cancer about as accurately as teledermatology or face-to-face review. Its assessors estimated that automated DERM could about halve urgent dermatologist referrals.","account":"DERM, from Skin Analytics, is AI software that assesses images of skin lesions referred on the NHS urgent suspected skin cancer pathway. It can work alone or with a second read by a clinician. The National Institute for Health and Care Excellence (NICE) published an early value assessment on 1 May 2025. In one study, automated DERM detected 96.0% of cancers against 93.8% for face-to-face dermatologists. In another, it detected 94.0% against 97.0% for teledermatology, with overlapping confidence intervals. The committee found no evidence that DERM is less sensitive than either. Unity Insights, which evaluated DERM at three NHS sites, reported data suggesting that automated DERM would flag fewer non-cancer lesions for further review than teledermatology alone. NICE's assessors estimated that automated DERM could about halve urgent referrals to a dermatologist among eligible lesions. NICE allowed DERM in NHS teledermatology for a three-year evidence generation period. Most evidence came from people with white skin, so NICE requires clinician review for people with black or brown skin. It is unclear whether DERM frees dermatology capacity."}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["summary","account"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"systems[].autonomy_permissions":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].component_role":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].deployment_configuration":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].inputs_outputs":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].model_name":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].model_version":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].product_name":{"state":"value_present","value":{"kind":"record_fields","fields":{"system":"DERM (Deep Ensemble for Recognition of Malignancy)"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["system"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"systems[].provider":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"taxonomy_crosswalks[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"title":{"state":"value_present","value":{"kind":"record_fields","fields":{"title":"NICE finds that DERM spots skin cancer about as accurately as dermatology review and allows it in NHS teledermatology while evidence is gathered","headline":"NICE assessors estimate that *DERM* could halve urgent skin referrals"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["title","headline"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"version":{"state":"value_present","value":{"kind":"identifiers","identifiers":["fae716343cb6a4665e6dd21196a37a4a2b8ce565a11278af6a5e87b7a2f4bead"],"role":"SHA-256 of the complete public record and its assessments"},"provenance":{"kind":"curatorial","basis":"SHA-256 of the public record, its assessments, and its displayed answers and notes, excluding its own identifier and the derived coverage summary.","record_fields":[],"source_refs":[]},"review_state":"record_mapped","coverage":"complete"},"workflow":{"state":"value_present","value":{"kind":"record_fields","fields":{"account":"DERM, from Skin Analytics, is AI software that assesses images of skin lesions referred on the NHS urgent suspected skin cancer pathway. It can work alone or with a second read by a clinician. The National Institute for Health and Care Excellence (NICE) published an early value assessment on 1 May 2025. In one study, automated DERM detected 96.0% of cancers against 93.8% for face-to-face dermatologists. In another, it detected 94.0% against 97.0% for teledermatology, with overlapping confidence intervals. The committee found no evidence that DERM is less sensitive than either. Unity Insights, which evaluated DERM at three NHS sites, reported data suggesting that automated DERM would flag fewer non-cancer lesions for further review than teledermatology alone. NICE's assessors estimated that automated DERM could about halve urgent referrals to a dermatologist among eligible lesions. NICE allowed DERM in NHS teledermatology for a three-year evidence generation period. Most evidence came from people with white skin, so NICE requires clinician review for people with black or brown skin. It is unclear whether DERM frees dermatology capacity.","replication":{"produced_by":["DERM assessed lesion images after a primary care referral to the urgent suspected skin cancer pathway.","DERM ran alone or with a clinician's second read."],"must_hold":["A clinician reviews the lesions of people with black or brown skin.","Services monitor DERM's accuracy regularly."],"echoes":[]}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["account","replication"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"}},"summary":{"total":91,"addressed":91,"known":29,"reviewed":2,"reviewed_complete":2,"reviewed_partial":0,"record_mapped":27,"review_not_assessed":62,"not_assessed":0,"complete":false,"by_state":{"value_present":29,"not_reported":0,"unresolved":62,"not_assessed":0,"not_applicable":0,"withheld":0,"source_unavailable":0}}},"presentation_version":"2b404281a12cd464acb21759555a8182628ae7ebebd034a4ea8433aa85cc6f4c"}